Sotalol Viatris (Sotalol Mylan) Tafla 80 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sotalol viatris (sotalol mylan) tafla 80 mg

viatris limited - sotalolum hýdróklóríð - tafla - 80 mg

Veklury Evrópusambandið - íslenska - EMA (European Medicines Agency)

veklury

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Dexamethasone hameln Stungulyf, lausn 4 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

dexamethasone hameln stungulyf, lausn 4 mg/ml

hameln pharma gmbh - dexamethasonum natríumfosfat - stungulyf, lausn - 4 mg/ml

Aldurazyme Evrópusambandið - íslenska - EMA (European Medicines Agency)

aldurazyme

sanofi b.v. - laronidasa - mucopolysaccharidosis i - Önnur meltingarvegi og efnaskipti vörur, - aldurazyme er ætlað til langtíma ensím skipti meðferð í sjúklinga með staðfest greining mucopolysaccharidosis ég (Þingmenn ég; alfa-l-iduronidase skort) til að meðhöndla nonneurological einkennum sjúkdómsins.

Flúoxetín Actavis Lausnartafla 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

flúoxetín actavis lausnartafla 20 mg

actavis group ptc ehf. - fluoxetine hydrochloride - lausnartafla - 20 mg

Fluoxetin Viatris (Fluoxetin Mylan) Hart hylki 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

fluoxetin viatris (fluoxetin mylan) hart hylki 20 mg

viatris limited - fluoxetinum hýdróklóríð - hart hylki - 20 mg

Fluoxetin WH Hart hylki 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

fluoxetin wh hart hylki 20 mg

williams & halls ehf - fluoxetine hydrochloride - hart hylki - 20 mg

Fontex Dreifitafla 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

fontex dreifitafla 20 mg

eli lilly danmark a/s - fluoxetinum hýdróklóríð - dreifitafla - 20 mg

Talzenna Evrópusambandið - íslenska - EMA (European Medicines Agency)

talzenna

pfizer europe ma eeig - talazoparib - brjóstakrabbamein - Æxlishemjandi lyf - talzenna er ætlað eitt og sér fyrir meðferð fullorðinn sjúklinga með germline brca1/2 stökkbreytingar, sem hafa her2-neikvæð staðnum háþróaður eða brjóstakrabbamein. patients should have been previously treated with an anthracycline and/or a taxane in the (neo)adjuvant, locally advanced or metastatic setting unless patients were not suitable for these treatments. sjúklingar með hormón viðtaka (hr)-jákvæð brjóstakrabbamein ætti að hafa verið meðhöndluð með áður en annarra byggir meðferð, eða að vera talin óhæf til annarra byggir meðferð.

Tevimbra Evrópusambandið - íslenska - EMA (European Medicines Agency)

tevimbra

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - Æxlishemjandi lyf - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.